Connor, Clark & Lunn Investment Management Ltd. Bio Techne Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$282.54 - $391.85 $770,204 - $1.07 Million	2,726 Added 116.85%	5,059 $1.44 Million
Q2 2022 Aug 05, 2022	BUY	$322.67 - $449.65 $752,789 - $1.05 Million	2,333 New	2,333 $809,000
Q4 2021 Feb 10, 2022	SELL	$456.15 - $525.06 $1.78 Million - $2.05 Million	-3,901 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$444.87 - $538.88 $1.74 Million - $2.1 Million	3,901 New	3,901 $1.89 Million
Q4 2019 Feb 12, 2020	SELL	$189.68 - $222.09 $203,906 - $238,746	-1,075 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$183.56 - $216.72 $197,327 - $232,974	1,075 New	1,075 $210,000

Others Institutions Holding TECH

# of Institutions

602

Shares Held

151M

Call Options Held

195K

Put Options Held

53.2K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.94B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account